Value-Based Care

As corporate giants swallow local clinics, one alliance offers a lifeline. Here’s how AllyGPO and BioCareSD use AI and service to help doctors stay independent.

EVERSANA poaches Takeda's Jen Norton to lead a new tech-first unit, signaling a high-stakes bid to dominate the complex life sciences access market.

Blue Cross MA's new partnership with Thyme Care moves beyond paying for procedures, betting on a value-based model to guide patients and curb spiraling costs.

Charta Health's new athenahealth partnership promises an 11% revenue lift by auditing every bill. We analyze if AI is the long-awaited cure for revenue leakage.

Priority Health partners with Color Health, leveraging an ASCO-certified virtual clinic to tackle soaring cancer costs and redefine access for employers.

Essence Healthcare and ŌURA's new partnership uses sleep data to screen for sleep apnea, marking a major shift from wellness perks to proactive clinical care.

A new clinical trial for a sacroiliac joint device isn't just about technology; it's about a company's bet that rigorous evidence is the best medicine for patients and the healthcare system.

A new Philips report quantifies AI's benefits in healthcare, from saving time to catching errors. But the path to adoption is fraught with challenges.

Dr. Farzad Mostashari’s recent accolade is more than an award; it’s a validation of a strategic model proving that realigning incentives can save billions.

New research from Baycrest unmasks paratonia, an involuntary condition often mistaken as defiance, signaling a seismic shift in dementia care and treatment.

As dementia costs Ontario $30 billion annually, a new task force is not just another committee. It's a strategic blueprint for dismantling a broken system.

Helsinki leverages its iconic Aalto architecture to redefine urban living, blending heritage with modern business strategy through exhibitions and a UNESCO bid.

New research shows 'Food is Medicine' programs thrive when paired with human coaching, offering a potent, scalable model for tackling chronic disease.

Dr. Brian Covino's top honor signals a shift in health tech, where AI doesn't replace doctors but learns from them. Can this model fix our broken system?

With expanded coverage for 52 million Americans, Tonix Pharmaceuticals' TONMYA® is not just a drug launch; it's a market disruption for chronic pain.

As GLP-1 drugs dominate, a UK biotech reveals a new drug that targets mitochondria, promising superior fat loss while preserving precious muscle mass.

Digital health firm Osara Health is targeting the 'Cancer Care Cliff,' backing its new survivorship program with a validated 25:1 ROI and proven health outcomes.

Zealand Pharma's petrelintide shows double-digit weight loss with remarkably few side effects, positioning it to challenge GLP-1 giants in the $100B market.

Ottawa's new "AI for All" plan promises to revolutionize healthcare, but can its 'ironclad protections' keep pace with the technology it's unleashing?

Amid a regional healthcare crisis, 475 nurses at BMC South plan to picket, citing unsafe staffing and a 'bullying' contract offer from management.